Jeffrey E. Russel

Array ( [id] => 7435939 [patent_doc_number] => 20040002448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Macrocyclic peptides active against the hepatitis C virus' [patent_app_type] => new [patent_app_number] => 10/358726 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37186 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002448.pdf [firstpage_image] =>[orig_patent_app_number] => 10358726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005441 [patent_doc_number] => 06906037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Therapeutic peptide-based constructs' [patent_app_type] => utility [patent_app_number] => 10/359013 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12318 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906037.pdf [firstpage_image] =>[orig_patent_app_number] => 10359013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797768 [patent_doc_number] => 20030176642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/354706 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10204 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176642.pdf [firstpage_image] =>[orig_patent_app_number] => 10354706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741463 [patent_doc_number] => 07030090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Immune-modulating peptide' [patent_app_type] => utility [patent_app_number] => 10/353419 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10999 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030090.pdf [firstpage_image] =>[orig_patent_app_number] => 10353419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638782 [patent_doc_number] => 20030211980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antimicrobial agents' [patent_app_type] => new [patent_app_number] => 10/351760 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10664 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211980.pdf [firstpage_image] =>[orig_patent_app_number] => 10351760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884563 [patent_doc_number] => 07351693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/502617 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 15048 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351693.pdf [firstpage_image] =>[orig_patent_app_number] => 10502617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843177 [patent_doc_number] => 20030148524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Method and device for electroporation of biological cells' [patent_app_type] => new [patent_app_number] => 10/346755 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6210 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148524.pdf [firstpage_image] =>[orig_patent_app_number] => 10346755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310380 [patent_doc_number] => 20040142875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Metastin derivatives and their use' [patent_app_type] => new [patent_app_number] => 10/337105 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17140 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142875.pdf [firstpage_image] =>[orig_patent_app_number] => 10337105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701136 [patent_doc_number] => 20030224016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Transport peptides such as C-terminal Erns peptide and analogues thereof' [patent_app_type] => new [patent_app_number] => 10/335057 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14255 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224016.pdf [firstpage_image] =>[orig_patent_app_number] => 10335057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206509 [patent_doc_number] => 20040087504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Novel peptide sy' [patent_app_type] => new [patent_app_number] => 10/472062 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6440 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087504.pdf [firstpage_image] =>[orig_patent_app_number] => 10472062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6850980 [patent_doc_number] => 20030143183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Combined use of a GLP-1 compound and another drug for treating dyslipidemia' [patent_app_type] => new [patent_app_number] => 10/328284 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6347 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143183.pdf [firstpage_image] =>[orig_patent_app_number] => 10328284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 363208 [patent_doc_number] => 07482018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Use of oligomers and polymers for drug solubilization, stabilization, and delivery' [patent_app_type] => utility [patent_app_number] => 10/328898 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18889 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482018.pdf [firstpage_image] =>[orig_patent_app_number] => 10328898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710990 [patent_doc_number] => 07056889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Compounds that bind P2Y2 or P2Y1 receptors' [patent_app_type] => utility [patent_app_number] => 10/320731 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10018 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056889.pdf [firstpage_image] =>[orig_patent_app_number] => 10320731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861620 [patent_doc_number] => 20030092628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Gonadotropin releasing hormone antagonist' [patent_app_type] => new [patent_app_number] => 10/319884 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2757 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092628.pdf [firstpage_image] =>[orig_patent_app_number] => 10319884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852008 [patent_doc_number] => 20030144211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Peptide inhibitors of inflammation mediated by selectins' [patent_app_type] => new [patent_app_number] => 10/319340 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11114 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144211.pdf [firstpage_image] =>[orig_patent_app_number] => 10319340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972200 [patent_doc_number] => 06936585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Corticotropin releasing factor 2 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/317252 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936585.pdf [firstpage_image] =>[orig_patent_app_number] => 10317252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515626 [patent_doc_number] => 07192924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Corticotropin releasing factor 2 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/317251 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21248 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192924.pdf [firstpage_image] =>[orig_patent_app_number] => 10317251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515603 [patent_doc_number] => 07192923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Corticotropin releasing factor 2 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/315964 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21226 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192923.pdf [firstpage_image] =>[orig_patent_app_number] => 10315964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658303 [patent_doc_number] => 07105489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Methods and compositions for treating polycystic ovary syndrome' [patent_app_type] => utility [patent_app_number] => 10/317126 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6542 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105489.pdf [firstpage_image] =>[orig_patent_app_number] => 10317126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725486 [patent_doc_number] => 20030207798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Use of 3-position cyclosporin derivatives for hair growth' [patent_app_type] => new [patent_app_number] => 10/303281 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10023 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207798.pdf [firstpage_image] =>[orig_patent_app_number] => 10303281 [rel_patent_id] =>[rel_patent_doc_number] =>)